OSE Immunotherapeutics SA
OSE.PA·Paris·Healthcare
2.0040−0.0380 (−1.86%)today
At close: Oct 23, 5:35 PM CEST · May be delayed up to 15 min · EUR
Prices may be delayed up to 15 min. Not investment advice. News volume: articles in the 4Search index each day.
Key statistics
Previous close2.0420
Open2.0680
Day range1.97602.0680
52-week range1.97606.2950
Off day high−3.09%
Off 52-week high−68.17%
Volume106.69K
Avg. volume (3M)141.17K
Market cap49.54M
EPS (TTM)-1.69
Forward P/E-1.76
P/E ratio (TTM)—
Dividend yield—
Beta (5Y)0.89
Shares outstanding24.72M
Short interest—
Earnings dateSep 28, 2026 (est.)
Analyst target11.8750
Profit margin0.00%
Against its peers
Compare in full ›| OSE.PA | HBP.TO | OSTX | ATORX.ST | CHRS | ACTI.ST | |
|---|---|---|---|---|---|---|
| Market cap | 49.54M | 62.63M | 58.51M | 6.34M | 156.05M | 90.81M |
| P/E (TTM) | — | — | — | — | — | — |
| Forward P/E | -1.8 | -7.5 | 3.6 | -0.1 | -1.6 | — |
| Price/book | 1.6 | 4.3 | -4.8 | 0.2 | 2.6 | 2.4 |
| Dividend yield | — | — | — | — | — | — |
| 1-year change | −67.01% | −53.11% | −33.86% | −99.15% | −36.36% | −50.00% |
| Today | −1.86% | −16.33% | 0.00% | −4.72% | −3.81% | +8.68% |
The closest companies by business and industry (Biotechnology). Prices may be delayed up to 15 min.
Latest news
All OSE.PA news ›OSE Immunotherapeutics to Present at Chardan’s 10th Annual Healthcare Conference
Nantes, France, October 15, 2026 - 7:30am CEST - OSE Immunotherapeutics SA (ISIN: FR0012127173; Mnemo: OSE), a clinical-stage biotech company dedicated to developing first-in-class therapies in immuno-oncology and immuno-inflammation,…
From articles in the 4Search news index.
In the news
1mentions in 30 days
1with it in the headline
Positivesentiment
Mentioned with
People in the coverage
Most coverage from
-
manilatimes.net1
Finance and business coverage in the 4Search news index: articles that name it in the headline, or in the text beside its ticker. Sentiment is the index's own reading of the latest 1 articles, not a forecast.